-- 
Can Fite Advances on Eye Division Spinoff to U.S. Company

-- B y   S h a r o n   W r o b e l
-- 
2011-06-05T14:58:09Z

-- http://www.bloomberg.com/news/2011-06-05/can-fite-rises-on-eye-division-spinoff-to-u-s-company.html
Can Fite BioPharma (CFBI)  Ltd. climbed for
the first time in three days after the biopharmaceutical company
signed an agreement to spin off its eye-disease division to U.S.
company Denali Concrete Management Inc.  The shares rose 0.3 percent, the most since May 31, to
0.719 shekel at the 4:30 p.m. close in  Tel Aviv . Can Fite
earlier advanced as much as 4.6 percent to 0.75 shekel.  To contact the reporter on this story:
Sharon Wrobel in Tel Aviv at 
 swrobel4@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  